IShares Global Financial Statements From 2010 to 2024
| IXJ Etf | USD 90.41 0.25 0.28% |
Check IShares Global financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IShares Global's main balance sheet or income statement drivers, such as , as well as many indicators such as . IShares financial statements analysis is a perfect complement when working with IShares Global Valuation or Volatility modules.
IShares |
iShares Global Healthcare ETF Price To Sales Analysis
IShares Global's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current IShares Global Price To Sales | 73.93 X |
Most of IShares Global's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, iShares Global Healthcare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
IShares Global Price To Sales Component Assessment
Based on the latest financial disclosure, iShares Global Healthcare has a Price To Sales of 73 times. This is much higher than that of the iShares family and notably higher than that of the Health category. The price to sales for all United States etfs is notably lower than that of the firm.
iShares Global Healthcare Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining IShares Global's current stock value. Our valuation model uses many indicators to compare IShares Global value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across IShares Global competition to find correlations between indicators driving IShares Global's intrinsic value. More Info.iShares Global Healthcare is considered the top ETF in price to earning as compared to similar ETFs. It also is considered the top ETF in price to book as compared to similar ETFs fabricating about 0.17 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for iShares Global Healthcare is roughly 5.96 . Comparative valuation analysis is a catch-all technique that is used if you cannot value IShares Global by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About IShares Global Financial Statements
Investors use fundamental indicators, such as IShares Global's revenue or net income, to determine how well the company is positioned to perform in the future. Although IShares Global's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
The fund generally invests at least 80 percent of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index and may invest up to 20 percent of its assets in certain futures, options and swap contracts, cash and cash equivalents. Global Healthcare is traded on NYSEARCA Exchange in the United States.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of IShares Global Correlation against competitors. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
The market value of iShares Global Healthcare is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Global's value that differs from its market value or its book value, called intrinsic value, which is IShares Global's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Global's market value can be influenced by many factors that don't directly affect IShares Global's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares Global's value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Global is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Global's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.